By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
ELV insiders were on both sides of the trade this year. Buys came to roughly $2.2 million (three buyers), sales to $1.7 million (four sellers).
The largest purchase came from COLLIS STEVEN H (Director), about $870,000. C-suite participation is part of the picture here.
1,604 investment managers listed ELV in their latest 13F filings (Q2 2026); more funds bought than sold. ELV also shows up in congressional disclosures: 19 reported trades from nine lawmakers in two years. Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 3 of the last 7 full quarters.
Are insiders buying or selling ELV stock?
In the last 12 months Elevance Health, Inc. insiders made open-market purchases worth about $2.2 million and sales worth about $1.7 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in ELV?
The most recent open-market insider trade in ELV was filed on 2026-07-17.
How many institutions own ELV?
1,604 investment managers reported holding ELV in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded ELV?
Yes. Members of Congress reported 19 trades in ELV over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).